drugset / Trial / NCT01491061

Ranolazine Loading to Prevent PCI-induced Myocardial Injury

NCT01491061

Phase 4 Unknown 100 enrolled University of Roma La Sapienza
RandomizedParallel-groupTriple-blindTreatment

Summary

It has previously been shown that pretreatment with ranolazine 1,000 mg twice daily for 7 days can significantly reduce procedural myocardial injury in elective percutaneous coronary intervention (PCI). The investigators tested the hypothesis that twice overnight high-dose ranolazine loading before PCI can reduce the peri-procedural myocardial ischemic damage similarly to long-term pre-treatment with standard doses.

Timeline

Start
2014-01
Primary completion
2015-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranolazine Small molecule 1000 mg Oral